3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Interventions
pembrolizumab
310
Carboplatin
159
Nivolumab
159
Cisplatin
141
Cyclophosphamide
135
Paclitaxel
129
Magnetic Resonance Spectroscopy
99
Specimen Handling
96
Radiotherapy
94
Gemcitabine
88
Dexamethasone
86
Biopsy
81
Ipilimumab
81
Docetaxel
78
Doxorubicin
77
Rituximab
71
Etoposide
69
Radiation
62
durvalumab
62
Lenalidomide
61
atezolizumab
61
Pemetrexed
59
Prednisone
59
Taxes
58
Bevacizumab
55
fludarabine
54
olaparib
53
Vincristine
52
Cytarabine
51
Fluorouracil
48
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
romiplostim
×
1 year
×
Clear all
NCT03362177
2026-02-11
RECITE
Amgen
Phase 3
Completed
165 enrolled
22 charts